Jazz Pharmaceuticals

3 Midsize Drug Stocks Moving On Q3 Reports
Investors.com
Tue, 11/10/15 - 04:27 pm
Jazz Pharmaceuticals
Depomed
Halozyme
Jazz eyes a quick FDA nod for its $1B rare disease drug
Fierce Biotech
Wed, 09/30/15 - 04:49 pm
Jazz Pharmaceuticals
FDA
Defibrotide
hepatic veno-occlusive disease
Jazz Pharma Could Be Worth Over $200 If Xyrem Adds Long-Term Value: Here's How
Yahoo/Benzinga
Fri, 07/31/15 - 03:12 pm
Jazz Pharmaceuticals
Xyrem
Jazz misses Street 1Q forecasts
Yahoo/AP
Fri, 05/8/15 - 08:55 am
Jazz Pharmaceuticals
earnings
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
AbbVie
AstraZeneca
Biomarin
Bristol-Myers Squibb
Celgene
Gilead Sciences
GSK
Hospira
Jazz Pharmaceuticals
Merck
Seattle Genetics
Shire
4 big biopharma deals we might see in 2015
BioPharma Dive
Mon, 04/6/15 - 10:51 am
M&A
Merck
Jazz Pharmaceuticals
Shire
Biomarin
Gilead Sciences
Seattle Genetics
Pfizer
Celgene
The Hottest Question in Pharma: Which Company Will Be Next To Sell?
WSJ Pharmalot
Tue, 03/17/15 - 10:19 am
M&A
Jazz Pharmaceuticals
Anacor
Perrigo Company
Kythera Biopharmaceuticals
Akorn
Impax Laboratories
Jazz tops Street 4Q forecasts
Yahoo/AP
Wed, 02/25/15 - 07:23 am
Jazz Pharmaceuticals
earnings
Jazz: After 18% In Gains, Earnings Lurk
Seeking Alpha
Fri, 01/23/15 - 10:50 am
Jazz Pharmaceuticals
earnings
Analyst’s Top 3 Biotech Picks for 2015 With Upside and Takeover Potential
24/7 Wall St
Fri, 01/9/15 - 10:44 am
M&A
Cempra
Jazz Pharmaceuticals
Kite Pharma
J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015
TheStreet.com
Mon, 12/22/14 - 09:47 am
Alexion
Biomarin
Bristol-Myers Squibb
Jazz Pharmaceuticals
Valeant Pharmaceuticals
Illumina
Jazz heads to the FDA with its $1B rare disease drug
Fierce Biotech
Mon, 12/15/14 - 08:28 am
Jazz Pharmaceuticals
FDA
Defibrotide
Gentium
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386
Yahoo/Zacks.com
Wed, 12/10/14 - 05:44 pm
Jazz Pharmaceuticals
JZP-386
Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem
Yahoo/Zacks.com
Wed, 12/3/14 - 09:40 am
Jazz Pharmaceuticals
Xyrem
narcolepsy
These 5 Drugmakers' Earnings Excelled This Quarter
Investors.com
Wed, 11/5/14 - 07:37 am
earnings
Alexion
Biogen Idec
Jazz Pharmaceuticals
Celgene
Allergan
Actavis
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
3 Likely Biotech Buyout Candidates
24/7 Wall St
Mon, 09/29/14 - 09:27 am
biotech
M&A
Alkermes
Jazz Pharmaceuticals
Salix
Jazz looks more attractive for Allergan than Salix, says Wells Fargo
The Fly on the Wall
Mon, 09/8/14 - 09:35 am
Jazz Pharmaceuticals
Allergan
Salix
M&A
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch
Investors.com
Wed, 08/27/14 - 09:56 am
Jazz Pharmaceuticals
Gilead Sciences
Illumina
Salix
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
Investors.com
Mon, 08/18/14 - 04:21 pm
earnings
Jazz Pharmaceuticals
Celgene
Alexion
Regeneron

Pages